Navigation Links
The probability of surviving nine types of cancer is analyzed
Date:7/15/2010

"The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way", Mara Dolores Chirlaque, main author of the study and researcher in the Epidemiology Service of the Department of Health and Consumption in Murcia, explains to SINC.

The investigation, which has been published in the journal Annals of Oncology, involved the participation of eight Spanish regions which currently hold a population record of cancer (Basque Country, Navarra, Girona, Tarragona, Castelln, Albacete, Murcia and Granada). It shows all the cases of cancer diagnosed between 1995 and 1999 (57,622), their monitoring until December 2004, and their prognosis.

The results enable us to understand the situation and survival five years after the diagnosis of eight malignant tumours in Spain (breast, lung, colon, rectum, prostate, ovary, testicle, melanoma and Hodgkin's lymphoma).

"When compared to the survival average in Europe, Spain is very close to the European average for the nine tumours studied, with differences less than 2%", highlights the researcher. The highest survival rate for most of the tumours is observed in Finland, Sweden, Norway and Iceland. On the other hand, the lowest corresponds to the Czech Republic, Poland and Slovenia.

As for Spain, the greatest differences have been detected in lung cancer (12.4% in Navarra as opposed to 6.1% in Granada), and the smallest, in breast cancer (91.3% in Castelln versus 81.2% in Albacete). [*More information in the table attached].

Survival percentages

"In the past cancer was considered to be fatal. However, nowadays it has come to be recognised as a curable illness", Chirlaque points out. "Testimony to this is the results shown in this study, which indicate that of every four people who suffer from it (with the exception of lung cancer), more than three overcome it".

  1. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years.

  2. Lung cancer is one of the most aggressive tumours and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

  3. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.

  4. Prostate cancer, today the most common tumour in men, has an increasingly favourable prognosis, with a global survival rate of 76%, which is higher in young adults.

  5. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

  6. Testicular cancer, a rare malignant tumour that mainly affects middle-aged males, is the tumour with the best prognosis, with a 95% survival rate five years after diagnosis.

  7. Skin melanoma displays one of the highest survival rates, reaching values over 85%, although there are European countries where recovery exceeds 90%.

  8. Hodgkin's lymphoma displays high recovery with survival greater than 92% amongst young people, although amongst elderly groups it fails to reach 50%.


'/>"/>

Contact: SINC
info@plataformasinc.es
34-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Related medicine news :

1. Social Security Disability Benefits Can Be Crucial to Surviving With Spinal Cord Injury, Allsup Reports
2. Surviving Cardiac Arrest Depends on Your Location
3. Chances of surviving cardiac arrest depends on your neighborhood
4. The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century
5. Behavior problems in school linked to 2 types of families
6. Friendships, family relationships get better with age thanks to forgiveness, stereotypes
7. Easy Lawsuit Funding Now Offers Lawsuit Loan on All Types of Employment Lawsuits
8. Effort to Cure Some Types of Hearing Loss Gets Big Boost
9. Simple Test May Identify Breast Cancer Subtypes
10. Simple gene test identifies clinically important subtypes of breast cancer
11. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The probability of surviving nine types of cancer is analyzed
(Date:5/31/2016)... ... 2016 , ... Psoriasis: Targets and Therapy has ... corresponding author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy ... the onset and the severity of psoriasis, and negatively influences the response to ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... calls back to particular advertising campaigns, to monitor the performance of sales and ... can maximize conversions and revenue. The software allows customers to record, transcribe, route, ...
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the multiple awards ... is home to Ontario’s leading day spa and one of Canada’s few accredited 5 ... a unique concept to combine spa services with hair and beauty services ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 According ... Biometrics Market by Technology (Single-factor (Fingerprint, Face, ... Application (Workforce Management), End User (Hospitals, Healthcare ... by MarketsandMarkets, the market is projected to ... USD 1,182.6 Million by 2016, at a ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
(Date:5/27/2016)... LabStyle Innovations Corp . ( ... today announced that the Company,s Chief Financial Officer, Zvi ... held June 1-2 in New York, NY ... in Los Angeles, CA. ... operational milestones, including the U.S. FDA Clearance and commercial launch ...
Breaking Medicine Technology: